Global Ectoparasiticides Market to Rise Considerably Owing to Increasing Prevalence of Zoonotic Diseases in Developing Economies, says Fortune Business Insights™ The global “Ectoparasiticides” market size is anticipated to grow owing to increasing awareness for animal safety in several economies. This information is published by Fortune Business Insights, in its upcoming report, titled “Ectoparasiticides Market Size, Share & Industry Analysis, By Product (Pour-on, Spot-on, Sprays, Dips, Oral tablets, Others), By Animal (Livestock, Companion), By End User (Veterinary Clinics, R & D Facilities, Farms, Others) and Regional Forecast, 2019-2026.” An ectoparasiticides is generally an antiparasitic drug usually for treating ectoparasitic infections in animals. This drugs are primarily beneficial to eliminate the parasites living on the animal skin. Well-known ectoparasiticides include permethrin, sulfur, lindane, crotamiton, and others. Parasites such as ticks, fleas, mites, lice, among others which severely affect the health of animals need to be treated to ensure safety and well-being of the infected animals. If untreated, these parasites result in severe complications such as failure of nervous system, and in some cases can even result in death of the animal. Rising awareness for the safety of animals is expected to drive the demand for the market in the forthcoming years. Competitive Landscape: Major companies in the Global Ectoparasiticides Market are increasingly focusing on research and development activities to create new and innovative products to stay ahead of the competition. Staying on top of market trends & drivers is crucial for decision-makers to hold this emerging opportunity. The study provides information on market trends and development, drivers, capacities, technologies, and the changing investment structure of the Ectoparasiticides Industry. Industrial Developments: • November 2018: Zoetis, a leading animal health company, receives FDA approval for its Revolution Plus. The drug is a combination of selamectin and sarolaner topical solution useful for treating several types of parasites affecting the animal health. • January 2018: Elanco, a division of Eli Lily AND Company, receives a nod of approval from FDA for its antidrug, Credelio. This antidrug is very effective as it kills fleas in the first 4 hours of its application, and kills about 99% parasites within 8 hours for the period of over 35 days. List of Companies Proliferating in the Market: • Bayer AG • Elanco • Boehringer Ingelheim International GmbH • Zoetis • Ceva • Virbac • Vetoquinol S.A. • Sanofi • Among others. https://www.fortunebusinessinsights.com/enquiry/sample/ectoparasiticides-market-101864